You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Continuous and intermittent sibutramine were equally effective at 44 weeks for reducing weight in obesity

https://doi.org/10.1136/ebm.7.2.46

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2001) JAMA 286, 1331. Wirth A, Krause J.. Long-term weight loss with sibutramine: a randomized controlled trial.. Sep 19;. :. –9.
    OpenUrlCrossRefPubMedWeb of Science

    
 
 QUESTION: In obese people, is sibutramine effective for reducing weight?

    Design

    Randomised (allocation concealed*), blinded (investigators and patients),* placebo controlled trial with 44 weeks of follow up after randomisation.

    Setting

    108 private practices and 3 hospital outpatient departments in Germany.

    Patients

    1001 patients who were 18 to 65 years of age (mean age 43 y, 77% women), had a body mass index (BMI) of 30 to 40 kg/m2, and had ≥ 1 previous unsuccessful attempt at losing weight by using dietary measures. Exclusion criteria were serious cardiovascular or metabolic diseases; history of drug or alcohol abuse; need for antidepressants, β;-blockers, or any drugs influencing body weight; or inadequate contraception in women of childbearing age. 79% of patients completed the study; all patients were included in the analysis.

    Intervention

    Patients who responded (ie, weight …

    View Full Text

    Footnotes

    • ↵* See glossary.

    • Source of funding: Knoll Deutschland GmbH

    • For correspondence: Dr A Wirth, Teutoburger-Wald-Klinik, Germany. wirthbr{at}t-online.de.